Seller record · Telehealth service
Alinwell
Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy; its pages say only partner compounding pharmacies in the United States. The published certificates of analysis are issued to Emerald Compounding Pharmacy in Tampa, Florida and Boudreaux's New Drug Store in Lake Charles, Louisiana, and no page presents either as the pharmacy that fills orders. 1 more criterion also fails; see the table below.
At a glance
AlinwellTelehealth service
- Price
- Semaglutide from $139 a month, tirzepatide from $166
- Sells
- compounded semaglutide, compounded tirzepatide, GLP-1 microdose, and 5 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A women's telehealth service selling compounded semaglutide and tirzepatide, a GLP-1 microdose program and oral GLP-1, with tesamorelin, sermorelin, NAD+ and PT-141 on its peptides page. It publishes certificates of analysis for four semaglutide and tirzepatide lots, and its privacy policy prints a placeholder address.
Operating entity Alinwell, LLC
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Alinwell's website; Alinwell's sermorelin product page |
| S2 | Prescription gating | PASS | Alinwell's eligibility page; Alinwell's website |
| S3 | Pharmacy identification | FAIL | Alinwell's NAD+ product page; Alinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document |
| S4 | Compounding disclosure | PASS | Alinwell's website; Alinwell's semaglutide product page |
| S5 | Analytical documentation | PASS | Alinwell's COA semaglutide 4mg document; Alinwell's COA semaglutide 2 5mg document; Alinwell's COA tirzepatide 10mg document; Alinwell's COA tirzepatide 20mg document |
| S6 | Business address | FAIL | Alinwell's contact page; Alinwell's privacy page |
| S7 | Price disclosure | PASS | Alinwell's website; Alinwell's peptides page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, GLP-1 microdose, oral GLP-1, compounded tesamorelin, sermorelin, NAD+, PT-141.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141Who sells tesamorelin
Unpaid link. Alinwell does not pay the site, and nothing is earned when it is used. Funding.
Visit AlinwellDispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.